 A second space age spanning omics, platforms and medicine across orbitsChristopher E. Mason (),
James Green,
Konstantinos I. Adamopoulos,
Evan E. Afshin,
Jordan J. Baechle,
Mathias Basner,
Susan M. Bailey,
Luca Bielski,
Josef Borg,
Joseph Borg,
Jared T. Broddrick,
Marissa Burke,
Andrés Caicedo,
Verónica Castañeda,
Subhamoy Chatterjee,
Christopher R. Chin,
George Church,
Sylvain V. Costes,
Iwijn De Vlaminck,
Rajeev I. Desai,
Raja Dhir,
Juan Esteban Diaz,
Sofia M. Etlin,
Zachary Feinstein,
David Furman,
J. Sebastian Garcia-Medina,
Francine Garrett-Bakelman,
Stefania Giacomello,
Anjali Gupta,
Amira Hassanin,
Nadia Houerbi,
Iris Irby,
Emilia Javorsky,
Peter Jirak,
Christopher W. Jones,
Khaled Y. Kamal,
Brian D. Kangas,
Fathi Karouia,
JangKeun Kim,
Joo Hyun Kim,
Ashley S. Kleinman,
Try Lam,
John M. Lawler,
Jessica A. Lee,
Charles L. Limoli,
Alexander Lucaci,
Matthew MacKay,
J. Tyson McDonald,
Ari M. Melnick,
Cem Meydan,
Jakub Mieczkowski,
Masafumi Muratani,
Deena Najjar,
Mariam A. Othman,
Eliah G. Overbey,
Vera Paar,
Jiwoon Park,
Amber M. Paul,
Adrian Perdyan,
Jacqueline Proszynski,
Robert J. Reynolds,
April E. Ronca,
Kate Rubins,
Krista A. Ryon,
Lauren M. Sanders,
Patricia Savi Glowe,
Yash Shevde,
Michael A. Schmidt,
Ryan T. Scott,
Bader Shirah,
Karolina Sienkiewicz,
Maria A. Sierra,
Keith Siew,
Corey A. Theriot,
Braden T. Tierney,
Kasthuri Venkateswaran,
Jeremy Wain Hirschberg,
Stephen B. Walsh,
Claire Walter,
Daniel A. Winer,
Min Yu,
Luis Zea,
Jaime Mateus and
Afshin Beheshti ()
Nature, 2024, vol. 632, issue 8027, 995-1008 Abstract: Abstract The recent acceleration of commercial, private and multi-national spaceflight has created an unprecedented level of activity in low Earth orbit, concomitant with the largest-ever number of crewed missions entering space and preparations for exploration-class (lasting longer than one year) missions. Such rapid advancement into space from many new companies, countries and space-related entities has enabled a ‘second space age’. This era is also poised to leverage, for the first time, modern tools and methods of molecular biology and precision medicine, thus enabling precision aerospace medicine for the crews. The applications of these biomedical technologies and algorithms are diverse, and encompass multi-omic, single-cell and spatial biology tools to investigate human and microbial responses to spaceflight. Additionally, they extend to the development of new imaging techniques, real-time cognitive assessments, physiological monitoring and personalized risk profiles tailored for astronauts. Furthermore, these technologies enable advancements in pharmacogenomics, as well as the identification of novel spaceflight biomarkers and the development of corresponding countermeasures. In this Perspective, we highlight some of the recent biomedical research from the National Aeronautics and Space Administration, Japan Aerospace Exploration Agency, European Space Agency and other space agencies, and detail the entrance of the commercial spaceflight sector (including SpaceX, Blue Origin, Axiom and Sierra Space) into aerospace medicine and space biology, the first aerospace medicine biobank, and various upcoming missions that will utilize these tools to ensure a permanent human presence beyond low Earth orbit, venturing out to other planets and moons. Date: 2024 Downloads: (external link) Related works: Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:632:y:2024:i:8027:d:10.1038_s41586-024-07586-8 Ordering information: This journal article can be ordered from DOI: 10.1038/s41586-024-07586-8 Access Statistics for this article Nature is currently edited by Magdalena Skipper More articles in Nature from Nature |
Is your work missing from RePEc? Here is how to contribute.
Questions or problems? Check the EconPapers FAQ or send mail to .
EconPapers is hosted by the
School of Business at Örebro University.